• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[感染时冷诱导血浆纤维连接蛋白肝素沉淀的有效性降低]

[Decreased effectiveness of cold-induced heparin precipitation of plasma fibronectin in infection].

作者信息

Vasil'ev S A, Efremov E E, Ermolin G A, Kotelianskiĭ V E, Ignashenkova G V

出版信息

Ter Arkh. 1986;58(10):117-23.

PMID:3798336
Abstract

Plasma fibronectin (FN) is one of the major blood opsonins. The content of the glycoprotein reduces in sepsis which in turn may aggravate the course of the infection. FN is detectable in the content of cryoglobulins and cryofibrinogen. The formation of the heparin precipitate following plasma incubation in the cold in the presence of heparin is determined by FN involvement. Fibrinogen (FG) is another main component of the heparin precipitate. To determine the functional activity of plasma FN in sepsis and other pathological conditions, a study was made of the ability of FN and FG to go into the precipitate formed in blood plasma in the cold after its incubation with heparin. Unlike normal subjects in whom over 80% of FN on the average and about 20% of FG went into the heparin precipitate, in patients with hemoblastoses and aplastic anemia complicated by sepsis, less than 40% of FN on the average and about 7% of FG went into the precipitate. In some patients with sepsis, the heparin precipitate did not form. The reduction of FN ability to go into the heparin precipitate correlated with the gravity of the patients' condition. In uncomplicated hemoblastoses, cryoglobulinemia and cryofibrinogenemia and in immunocomplex pathology, the consumption of FN and FG during heparin precipitate formation did not significantly differ from the control. The data indicate that sepsis patients with blood system pathology may develop not only quantitative FN deficiency in the blood but also disorder of the functional activity of the opsonin.

摘要

血浆纤连蛋白(FN)是主要的血液调理素之一。在脓毒症中,这种糖蛋白的含量会降低,进而可能加重感染进程。在冷球蛋白和冷纤维蛋白原中可检测到FN。血浆在冷环境中与肝素孵育后形成肝素沉淀的过程与FN有关。纤维蛋白原(FG)是肝素沉淀的另一个主要成分。为了确定脓毒症及其他病理状况下血浆FN的功能活性,对FN和FG在与肝素孵育后于冷环境中在血浆中形成沉淀的能力进行了研究。与正常受试者相比,正常受试者平均超过80%的FN和约20%的FG会进入肝素沉淀,而患有血液病和再生障碍性贫血并发脓毒症的患者,平均只有不到40%的FN和约7%的FG进入沉淀。在一些脓毒症患者中,未形成肝素沉淀。FN进入肝素沉淀的能力降低与患者病情的严重程度相关。在未并发的血液病、冷球蛋白血症和冷纤维蛋白原血症以及免疫复合物病理状况下,肝素沉淀形成过程中FN和FG的消耗与对照组无显著差异。数据表明,患有血液系统病理状况的脓毒症患者不仅可能出现血液中FN的定量缺乏,还可能出现调理素功能活性紊乱。

相似文献

1
[Decreased effectiveness of cold-induced heparin precipitation of plasma fibronectin in infection].[感染时冷诱导血浆纤维连接蛋白肝素沉淀的有效性降低]
Ter Arkh. 1986;58(10):117-23.
2
[Plasma fibronectin level in patients with depression of hematopoiesis].[造血功能低下患者的血浆纤维连接蛋白水平]
Ter Arkh. 1985;57(7):119-24.
3
[Changes in fibronectin concentration during therapeutic plasmapheresis. Therapeutic effectiveness of selective removal of fibronectin in immune complex pathology].[治疗性血浆置换过程中纤连蛋白浓度的变化。免疫复合物病理学中选择性去除纤连蛋白的治疗效果]
Ter Arkh. 1984;56(6):35-9.
4
[Plasma heparin precipitate as a source of fibronectin in the treatment of patients with trophic skin lesions].[血浆肝素沉淀物作为纤维连接蛋白的来源用于营养性皮肤损伤患者的治疗]
Ter Arkh. 1987;59(6):127-30.
5
Decreased plasma fibronectin in neonatal sepsis.
Pediatrics. 1983 Dec;72(6):877-81.
6
[Dynamics of the plasma fibronectin level in patients with food poisoning].[食物中毒患者血浆纤维连接蛋白水平的动态变化]
Ter Arkh. 1988;60(11):71-5.
7
Fibronectin and other DIC-related variables in septic ICU patients receiving cryoprecipitate.
Scand J Clin Lab Invest Suppl. 1985;178:67-74.
8
Sepsis and antithrombin III, prekallikrein, and fibronectin levels in surgical patients.
Am Surg. 1989 Jul;55(7):450-6.
9
Cellular fibronectin in plasma: its implications in fibrinogen-associated cryoprecipitation and other related reactions.
Blood Coagul Fibrinolysis. 1993 Feb;4(1):127-31.
10
Fibronectin and other DIC-related variables in patients with moderately severe infections receiving cryoprecipitate.
Scand J Clin Lab Invest Suppl. 1985;178:57-65.